肝细胞癌中的乙型肝炎病毒前基因组RNA:一种疾病分类与预后决定因素
研究分析了99例乙型肝炎表面抗原阳性、病毒学抑制后接受肿瘤切除或肝移植患者的肝细胞癌组织与非肿瘤肝组织,检测HBV DNA、RNA、cccDNA和pgRNA。肿瘤中cccDNA和pgRNA检出率分别为39%和67%,低于非肿瘤肝组织的66%和90%(P<0.01)。肿瘤中pgRNA和cccDNA检出与无微血管侵犯及更好生存相关,pgRNA阳性肝癌具有低细胞周期和DNA修复标志物表达及HBV受体表达特征。
要点
- 肿瘤中HBV cccDNA和pgRNA检出率分别为39%和67%,低于非肿瘤肝组织的66%和90%(P<0.01)。
- 肿瘤中pgRNA和cccDNA检出与无微血管侵犯及更好患者生存相关。
- pgRNA阳性肝癌细胞周期和DNA修复标志物表达低,并表达HBV受体,提示高分化肿瘤。
核心结论
- 复制HBV的肝细胞癌代表一种弱侵袭性肝细胞癌亚型,具有转录组特征。
- 来自非整合完整HBV基因组的pgRNA是病毒复制和预后的敏感标志物。
研究设计与样本
- 分析了99例乙型肝炎表面抗原阳性、病毒学抑制后接受肿瘤切除或肝移植患者的肝细胞癌组织与非肿瘤肝组织样本中的病毒和细胞参数。
主要发现
- 多数病例的肿瘤和非肿瘤样本中均可检测到总HBV DNA和RNA,但仅一部分肿瘤可检测到HBV cccDNA和pgRNA(39%和67%),低于非肿瘤肝组织(66%和90%;P<0.01)。
- 对游离型X基因测序显示11例中肿瘤与配对非肿瘤样本的HBV基因型不同。
- 肿瘤中pgRNA和cccDNA检出与无肿瘤微血管侵犯及更好患者生存相关。
- Agilent微阵列基因表达谱分析显示,pgRNA阳性肝细胞癌的细胞周期和DNA修复标志物水平低,并表达HBV受体钠牛磺胆酸共转运多肽,提示高分化肿瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hepatitis B virus (HBV) is a major cause of hepatocellular carcinoma (HCC). However, very little is known about the replication of HBV in HCC tissues. We analyzed viral and cellular parameters in HCC (T) and nontumor liver (NT) samples from 99 hepatitis B surface antigen (HBsAg)-positive, virologically suppressed patients treated by tumor resection or liver transplantation. We examined total HBV DNA and RNA as well as covalently closed circular DNA (cccDNA) and pregenomic RNA (pgRNA), which are considered as markers of active HBV replication. Total HBV DNA and RNA were detected in both T and NT samples in a majority of cases, but only a subset of tumors harbored detectable levels of HBV cccDNA and pgRNA (39% and 67%) compared to NT livers (66% and 90%; P < 0.01). Further evidence for HBV replication in tumor tissues was provided by sequencing of the X gene derived from episomal forms, showing that HBV genotypes differed between T and matched NT samples in 11 cases. The detection of pgRNA and cccDNA in tumors was correlated to the absence of tumorous microvascular invasion and to better patient survival. Analysis of gene expression profiles by Agilent microarrays revealed that pgRNA-positive HCCs were characterized by low levels of cell cycle and DNA repair markers and expression of the HBV receptor, sodium taurocholate cotransporting polypeptide, indicating well-differentiated tumors. CONCLUSION: HCC replicating HBV represents a subtype of weakly invasive HCC with a transcriptomic signature. pgRNA originating from nonintegrated, complete HBV genomes is a sensitive marker for viral replication and prognosis. (Hepatology 2018;67:86-96).
引用
- Halgand B, Desterke C, Rivière L, et al. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant. Hepatology. 2018. PMID: 28802063. doi:10.1002/hep.29463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。